Adverse effects of TNF inhibitors in SpA: are they different from RA?
about
Monitoring ankylosing spondylitis: clinically useful markers and prediction of clinical outcomes.Different roles of TNF inhibitors in acute anterior uveitis associated with ankylosing spondylitis: state of the art.Risk of infection in patients with spondyloarthritis and ankylosing spondylitis receiving antitumor necrosis factor therapy: A meta-analysis of randomized controlled trials.Efficacy and safety of secukinumab in Asian patients with active ankylosing spondylitis: 52-week pooled results from two phase 3 studies.Stevens-Johnsons syndrome or drug-induced lupus - a clinical dilemma: A case report and review of the literature.A Rare Adverse Effect of Anti-Tumor Necrosis Factor Alpha Therapy: Sarcoidosis
P2860
Adverse effects of TNF inhibitors in SpA: are they different from RA?
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Adverse effects of TNF inhibitors in SpA: are they different from RA?
@en
type
label
Adverse effects of TNF inhibitors in SpA: are they different from RA?
@en
prefLabel
Adverse effects of TNF inhibitors in SpA: are they different from RA?
@en
P1476
Adverse effects of TNF inhibitors in SpA: are they different from RA?
@en
P2093
Irene E van der Horst-Bruinsma
P304
P356
10.1016/J.BERH.2014.10.001
P577
2014-10-31T00:00:00Z